GERN
NASDAQ · Biotechnology
Geron Corp
$1.28
-0.01 (-0.78%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,385.2% upside
Low Target
$12.94
Average Target
$19.01
High Target
$24.33
Current Price
$1.28
Current
$1.28
$1.28
Target
$19.01
$19.01
$12.94
$19.01 avg
$24.33
Scenario Analysis
Bear Case
$12.94
910.9%
Low target
Base Case
$19.01
+1,385.2%
Avg target
Bull Case
$24.33
+1,800.8%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.01
-36.3% from high
52-Week Low
$1.04
+23.1% from low
Target vs 52W High
$19.01
+845.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |